期刊文献+

炎性肠病药物治疗的演进 被引量:2

原文传递
导出
摘要 随着对IBD的临床表现及其发病机制认识的深入、药物开发的进展、对IBD药物治疗临床证据的积累,IBD药物治疗所使用的品种、方案和策略逐渐演进。遵循循证医学证据的临床指南的推荐意见仍然推荐"上阶梯"的药物治疗策略。
出处 《临床药物治疗杂志》 2011年第2期13-16,共4页 Clinical Medication Journal
  • 相关文献

参考文献11

  • 1Allchin WH. Uleuative Colilis. An address introduetory, to the subject[J]. Proc Roy Soc Med,1909,2 :59- 75.
  • 2Kirner JB. Historieal aspects of inflammatory bowel disease[ J ]. J Clin Gastroenterol. 1988,10:286-97.
  • 3Svartz N. Sulfasalazine, 11. Some notes on the discovery, and devel- opment of salazopyrin[J]. Am J Gastroenterol,1988 ,83 :497- 503.
  • 4Svartz N. Salaropyrin - a nev, sulfanilamide preparation. A. Therapeutic resuh in rheumatoid arlhritis. B. Therapeutie resuhs in ul-eerative colitis. C. Toxic manifestations on lreatment with sulfanila- midc preparations[J]. Aeta Mcd Stand, 1942,110:577-590.
  • 5Azad - Khan AK, Pirls J, Truelove SC. An experiment to deter- mine the active therapeutic moiety of sulphasalazine, [J]. Lancet, 1977,2:892- 895.
  • 6Truelove SC, Witts LJ. Cortisone in uleerative colitis. Report on therapeutic trial[J]. Br Med.J,1955,2:1041-8.
  • 7Bean RHD. The treatment of chronic ulcerative colitis with 6 - mercaptopurine[J]. Med J Aust,1962,1:592- 593.
  • 8Bowen GE, Irons GV, Rhodes JB, et al. Early experiences with azathioprine in ulcerative colitis; a note of caution [J]. JAMA, 1966, 195:460- 464.
  • 9Targan SR, Hanauer SB, van Deventer S J, et al. A short - term study of chimeric monoclonal antibody cA2 to tumor necrosis factoralpha for Crohn's disease. Crohn's Disease cA2 Study Group[ J]. N Engl J Med,1997, 337:1029- 1035.
  • 10Bernstein CN, Fried M, Krabshuis JH,et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in2010[J]. Inflamm Bowel Dis, 2010,16:112-124.

二级参考文献21

  • 1Bernstein CN,Fried M,Krabshuis JH,et al.World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010.Inflamm Bowel Dis,2010,16:112-124.
  • 2Truelove SC,Witts U.Cortisone in ulcerative colitis; final report on therapeutic trial.Br Med J,1955,2:1041-1048.
  • 3Sutherland LR,Martin F,Greer S,et al.5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis,proctosigmoi-ditis,and proctitis.Gastroenterology,1987,92:1894-1898.
  • 4Elliott PR,Lennard-Jones JE,Hathway N.Simple index of Crohn's disease activity.Lancet,1980,1:876.
  • 5Carter MJ,Lobo AJ,Travis SP.Guidelines for the management of inflammatory bowel disease in adults.Gut,2004,53:V1-V16.
  • 6Lichtenstein GR,Abreu MT,Cohen R,et al.American Gastroenterological Association Institute medical position statement on corticosteroids,immunomodulators,and infliximab in inflammatory bowel disease.Gastroenterology,2006,130:935-939.
  • 7Lichtenstein GR,Abreu MT,Cohen R,et al.American Gastroenterological Association Institute technical review on corticosteroids,immunomodulators,and infliximab in inflammatory bowel disease.Gastroenterology,2006,130:940-987.
  • 8Hanauer SB,Sandborn WJ,Rutgeerts P,et al.Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease:the CLASSIC-I trial.Gastroenterology,2006,130:323-333.
  • 9Schreiber S,Rutgeerts P,Fedorak RN,et al.A randomized,placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease.Gastroenterology,2005,129:807-818.
  • 10Jarnerot G,Hertervig E,Friis-Liby I,et al.Infliximab as rescue therapy in severe to moderately severe ulcerative colitis:a randomized,placebo-controlled study.Gastroenterology,2005,128:1805-1811.

共引文献45

同被引文献1624

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部